Together with our results that demonstrated high LEFTY expression in Em Cas of advanced stages and with deep myometrial invasion, it appears that LEFTY may have anti-tumor effects through suppression of aggressive tumor growth by blocking TGF-β/Smad2 action in Em Cas. The gene discussed is TGFB1; the disease is neoplasm.